ProjectRecall.com

Product Recall News...Now Covering CoronaVirus
Get inspirations of what to cook with
 YummyScan
aad.org
11-26-2020
2021 AAD Annual Meeting is canceled due to COVID-19
Academy Meeting has been canceled due to the COVID-19 public health emergency. AAD President Bruce H. Thiers, MD, FAAD, sent the message below to all Academy members and others who planned to attend the 2021 Annual Meeting on Nov.
Herald Whig
11-24-2020
Inmate deaths connected to COVID-19 rise sharply in Missouri
Missouri prisons have seen a surge of inmate deaths connected to the coronavirus this month, prompting civil rights leaders to urge additional steps to protect prisoners
IRS
11-14-2020
Taxpayer Relief Initiative aims to help those financially affected by COVID-19
The IRS reviewed its collection activities to see how it could provide relief for taxpayers who owe taxes but are struggling financially because of the pandemic. The agency is expanding taxpayer options for making payments and other ways to resolve tax debt.
NPPES
11-12-2020
Trump Administration Partners with Chain and Independent Community Pharmacies to Increase Access to Future COVID-19 Vaccines
To maximize access to COVID-19 vaccines for all Americans, the U.S. Department of Health and Human Services (HHS) today announced the U.S. government’s partnerships with large chain pharmacies and networks that represent independent pharmacies and regional chains.
9NEWS
11-7-2020
Reports: White House Chief of Staff Mark Meadows has coronavirus
He becomes the latest White House staffer to contract the disease since President Donald Trump was diagnosed in early October.
CNBCTV18 on MSN.com
10-28-2020
GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance
The first results from an early mid-stage study of the Sanofi-GSK vaccine are expected in early December 2020, and the companies plan to file for regulatory approval in 2021.
CNBCTV18 on MSN.com
10-27-2020
Novavax delays US trial of COVID-19 vaccine to November
The US-based drug developer said data from a separate Phase III trial being conducted in Britain was expected by the first quarter of 2021 and could be the basis for global regulatory approvals although it did not elaborate.